WASATCH ADVISORS INC 13D and 13G filings for Castle Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 6:44 pm Sale | 2024-11-13 | 13G | Castle Biosciences, Inc. CSTL | WASATCH ADVISORS INC | 1,826,092 6.600% | -764,859 (-29.52%) | Filing |
| 2024-02-09 12:43 pm Sale | 2024-02-09 | 13G | Castle Biosciences, Inc. CSTL | WASATCH ADVISORS INC | 2,590,951 9.600% | -631,611 (-19.60%) | Filing |
| 2023-02-09 5:21 pm Purchase | 2023-02-09 | 13G | Castle Biosciences, Inc. CSTL | WASATCH ADVISORS INC | 3,222,562 12.200% | 106,074 (+3.40%) | Filing |
| 2022-02-10 5:23 pm Purchase | 2022-02-10 | 13G | Castle Biosciences, Inc. CSTL | WASATCH ADVISORS INC | 3,116,488 12.300% | 609,423 (+24.31%) | Filing |
| 2021-06-10 11:46 am Purchase | 2021-06-10 | 13G | Castle Biosciences, Inc. CSTL | WASATCH ADVISORS INC | 2,507,065 10.000% | 442,234 (+21.42%) | Filing |
| 2021-02-11 1:32 pm Purchase | 2021-02-11 | 13G | Castle Biosciences, Inc. CSTL | WASATCH ADVISORS INC | 2,064,831 8.400% | 2,064,831 (New Position) | Filing |